News

BIOFUTUR, The CRISPR/Cas9 patents: an endless war ?

An update of the situation to the French readers of monthly magazine “BIOFUTUR” (published in December 2017). Read the article: Marion Chajmowicz, BIOFUTUR, May 2017, 386 :51-53 Brevets Crispr/Cas9: une guerre sans fin ?

18 December 2017

Learn more

BIOFUTUR, march 2017 : Make US patents great again

Protecting an invention in Life Sciences and diagnostics has become more and more tricky in the U.S. An update of the situation to the French readers of monthly magazine “BIOFUTUR”. Read the article: Marion Chajmowicz et Ludovic Le Guen, BIOFUTUR, mars 2017, 384: 52-53, Make US patents great again

15 April 2017

Learn more

Requesting nullity of a patent in France: beware of time limitations

However on March 16, 2017, the judges decided that Actelion Pharmaceuticals’ request for invalidating European patent No. 1 200 092 owned by ICOS Corporation had not been timely lodged. The Court referred to the statutory period of limitation which restricts civil actions to “five years following the day on which the owner of a right […]

9 April 2017

Learn more

1 2 3
Des atomes 11

Contact






    If you would like more information, please do not hesitate to contact us. Please fill in the online form.

    Paris

    Cabinet Becker et Associés

    25 rue Louis Le Grand

    75002 Paris

    Métro : Opéra

    Parking : Opéra-Meyerbeer

    +33 (0)1 53 43 85 00

    Aix-en-Provence

    Cabinet Becker et Associés

    32 cours Mirabeau

    13100 Aix-en-Provence

    Parking : Mignet

    Social media & sharing icons powered by UltimatelySocial